The government, which has started to support domestic vaccine development, is expected to provide unconventional incentives to clinical participants.
Minister of Health and Welfare Kwon Deok-cheol held a meeting with the heads of hospitals conducting clinical trials for the COVID-19 vaccine on the 19th. At the meeting, topics such as providing incentives for clinical participants, vaccination for them, and support for sample analysis were discussed.
Currently, seven companies, including SK Bioscience, are conducting clinical trials for a COVID-19 vaccine in Korea. First, the government decided to support about 3,000 clinical trial intentions secured in advance through the National Clinical Trial Foundation in connection with companies.
Certificates are issued to clinical trial participants. By presenting the relevant certificate, you can receive a discount or exemption from admission fees for public institutions such as the National Science Museum, the National Institute of Ecology, and the Korea Cultural Heritage Foundation.
In addition, the discount measures that local governments have provided to those previously vaccinated against COVID-19 are also planned to be applied to clinical trial participants. If the plan is successful, clinical trial participants can also receive discounts on facility usage fees at Sejong Center for the Performing Arts, Incheon National Sports Center, Seoul Philharmonic Orchestra, and Busan Cinema Center.
Clinical participants can also receive volunteer hours of up to 4 hours at a time. Vaccinations due to participation in phase 3 clinical trials will also receive a vaccination certificate and take vaccine leave.